Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
NCT00522639
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
120
Enrollment
OTHER
Sponsor class
Stopped
Poor accrual
Conditions
Lung Cancer
SCLC
NSCLC
Interventions
OTHER:
18F-deoxyglucose (FDG)
Sponsor
Maastricht Radiation Oncology
Collaborators
[object Object]